July 14, 2025 - EverGlade Consulting

July 14, 2025

Biothreat Pathogens

BARDA Launches RFP for vaccines targeting Marburg virus (MARV) and Sudan ebolavirus (SUDV)

BARDA RFP – Marburg Virus and Sudan Ebolavirus Vaccine Licensure and Procurement On July 12, 2025, the Biomedical Advanced Research and Development Authority (BARDA) issued Request for Proposals (RFP) #75A50125R00006. This RFP seeks proposals for the advanced development, FDA licensure, and procurement of vaccines targeting Marburg virus (MARV) and Sudan ebolavirus (SUDV). With recent outbreaks […]

BARDA Launches RFP for vaccines targeting Marburg virus (MARV) and Sudan ebolavirus (SUDV) Read More »

Close up of blue antibiotic capsules

BARDA Launches New RFP to Bolster Antibiotic Stockpiles Against Drug-Resistant and Biothreat Pathogens

Request for Proposals (RFP) for Antibiotic for Treatment of Bacterial Pneumonia or Bloodstream Infections Bolstering Biodefense with Advanced Antibiotics: BARDA’s Strategic Move As the threat of antibiotic-resistant infections intensifies, the U.S. Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has issued a pivotal solicitation under Project BioShield

BARDA Launches New RFP to Bolster Antibiotic Stockpiles Against Drug-Resistant and Biothreat Pathogens Read More »

Scroll to Top